Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Other financing activities: 2009-2018

Historic Other financing activities for OptimizeRx (OPRX) over the last 4 years, with FY2018 value amounting to $1.9 million.

  • OptimizeRx's Other financing activities rose 32432.65% to $4.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $13.3 million, marking a year-over-year increase of 31892.59%. This contributed to the annual value of $1.9 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from FY2018, OptimizeRx's Other financing activities is $1.9 million.
  • Over the past 5 years, OptimizeRx's Other financing activities peaked at $1.9 million during FY2018, and registered a low of $1.9 million during FY2018.